Expertise in Non-Conventional Yeasts
Specialization in engineering yeasts (Candida, Yarrowia) capable of utilizing hydrophobic substrates for high-titer production of dicarboxylic acids.
Sebacic Acid is a crucial bio-monomer used in the production of high-performance polymers (like Nylon 6,10) and plasticizers. Traditionally, it is derived through the chemical cracking of castor oil, a source that is highly susceptible to price volatility and limited geographical availability, leading to variable costs and supply chain instability.
CD Biosynsis focuses on developing highly efficient microbial cell factories for the sustainable production of Sebacic Acid. We employ precise metabolic engineering strategies to optimize the omega-oxidation pathway in non-conventional yeasts, such as Candida tropicalis or Yarrowia lipolytica, enabling the efficient conversion of renewable feedstocks like n-alkanes or fatty acids. Our goal is to achieve high titer and yield of Sebacic Acid by preventing its further degradation, ensuring an economically competitive and reliable bio-monomer source.
Get a QuoteDeveloping bio-based Sebacic Acid production faces several critical biological and industrial limitations:
Overcoming these challenges requires metabolic reprogramming to prioritize the synthesis and accumulation of the C10 dicarboxylic acid monomer.
CD Biosynsis applies advanced synthetic biology and metabolic engineering to enhance the sustainable production of Sebacic Acid:
Optimization of Omega-Oxidation Pathway
We engineer Cytochrome P450 monooxygenases and associated reductases (e.g., in Candida tropicalis) to enhance the specific conversion of n-Decane or C10 fatty acids to Sebacic Acid.
Beta-Oxidation Knockout Strategy
We employ gene knockout of the beta-oxidation pathway to completely eliminate the degradation of Sebacic Acid, ensuring its efficient accumulation and high final product titer.
Enhanced Substrate Utilization
We modify cell membrane and transport systems to improve the uptake of hydrophobic substrates (alkanes/fatty acids) and increase cell tolerance to high substrate/product concentrations.
Cofactor Regeneration Engineering
We engineer metabolic pathways to increase the supply and regeneration rate of NADPH, the essential cofactor for the Cytochrome P450 system, boosting pathway flux.
This targeted engineering of non-conventional hosts ensures a reliable, high-yield route for bio-based Sebacic Acid production.
Choosing CD Biosynsis's Sebacic Acid strain engineering service offers the following core value:
Expertise in Non-Conventional Yeasts
Specialization in engineering yeasts (Candida, Yarrowia) capable of utilizing hydrophobic substrates for high-titer production of dicarboxylic acids.
Maximized Product Accumulation
Beta-oxidation knockout ensures that the Sebacic Acid product is not degraded, leading to a significantly higher final titer and yield.
Stable and Sustainable Supply Chain
Reduces reliance on variable castor oil supply by utilizing more abundant, low-cost alkanes or fatty acids as feedstocks.
Efficient Cofactor Utilization
Engineering efforts are focused on energy balance to ensure optimal availability of NADPH, eliminating a major bottleneck in the P450 system.
High Purity for Polymerization
The targeted metabolic strategy minimizes side products, ensuring the final Sebacic Acid meets the purity standards required for Nylon 6,10 and plasticizer production.
We are dedicated to providing genetically superior microbial strains to drive the commercial success of the bio-based dicarboxylic acid market.
CD Biosynsis's Sebacic Acid strain engineering service follows a standardized research workflow, ensuring every step is precise and controllable:
Technical communication is maintained throughout the process, focusing on timely performance feedback and strategic adjustments to the metabolic engineering plan.
Accelerate your Bio-based Sebacic Acid R&D and scale-up! CD Biosynsis provides customized strain engineering solutions:
Why is Candida tropicalis or Yarrowia lipolytica preferred for Sebacic Acid?
These non-conventional yeasts naturally possess a robust omega-oxidation pathway and have an inherent ability to utilize hydrophobic substrates like n-alkanes or fatty acids, making them superior hosts for dicarboxylic acid production compared to E. coli.
How does knocking out beta-oxidation improve the yield?
Beta-oxidation is the pathway that breaks down fatty acids and dicarboxylic acids for energy. By knocking it out, we prevent the cell from consuming the final Sebacic Acid product, forcing it to accumulate in the fermentation broth, drastically increasing the yield and titer.
What feedstocks can be used for this process?
The engineered strains are typically designed to utilize C10 fatty acids or n-Decane (C10 alkane). This provides flexibility to use various abundant, low-cost lipid-derived or petroleum-derived sources.
What is the role of Cytochrome P450 in this pathway?
Cytochrome P450 monooxygenases initiate the omega-oxidation pathway by hydroxylating the terminal methyl group of the alkane or fatty acid, which is the first and often rate-limiting step in converting the substrate into a dicarboxylic acid.
What is the estimated project timeline?
Due to the complexity of engineering non-conventional yeasts and optimizing hydrophobic substrate utilization, a complete project, including pathway editing, beta-oxidation knockout, and fermentation validation, typically requires 18-24 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.